NCT04715698View on ClinicalTrials.gov

Effectiveness of A Hemodynamic-Guided Treatment Strategy to Improve Blood Pressure Control

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

December 31, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Hypertension
Interventions
OTHER

ICG-guided drug selection

anti-hypertensive drug selection based on patient's hemodynamic profiling and physician's experience

OTHER

empirical drug selection

anti-hypertensive drug selection based on physician's experience only

Trial Locations (1)

Unknown

Peking University People's Hospital, Beijing

All Listed Sponsors
collaborator

Yale University

OTHER

collaborator

Shanghai Jiao Tong University School of Medicine

OTHER

lead

Peking University People's Hospital

OTHER

NCT04715698 - Effectiveness of A Hemodynamic-Guided Treatment Strategy to Improve Blood Pressure Control | Biotech Hunter | Biotech Hunter